The aim of the current study was to perform two separate meta-analyses of available studies comparing low-molecular-weight heparins (LMWHs) vs. unfractionated heparin (UFH) in ST-elevation myocardial infarction (STEMI) patients treated (i) with primary percutaneous coronary intervention (pPCI) or (ii) with PCI after thrombolysis
Background: Unfractionated heparin is often used as adjunctive therapy with fibrinolysis in patients...
Aims: The aim of the study was to compare outcomes in unfractionated heparin (UFH) and bivalirudin-t...
Background: Unfractionated heparin (UFH) is frequently administered before percutaneous coronary int...
Background: The aim of the current study was to perform two separate meta-analyses of available stud...
This systematic review with meta-analysis sought to determine the efficacy and safety of unfractiona...
AbstractThis systematic review with meta-analysis sought to determine the efficacy and safety of unf...
BACKGROUND: Whether low-molecular-weight heparin (LMWH) is superior to unfractionated heparin (UFH) ...
Background Despite its limitations, unfractionated heparin (UFH) is the recommended anticoagulant du...
SummaryBackgroundWhether low molecular weight heparin (LMWH) enoxaparin is equivalent to unfractiona...
Background Low-molecular-weight heparin has a number of pharmacological and pharmacokinetic advantag...
PURPOSE: To obtain reliable estimates of the relative efficacy and safety of low-molecular-weight he...
Background: Despite the overwhelming progress that has been accomplished in the prevention of mortal...
BackgroundLow-molecular-weight heparins have recently been introduced in the management of ST elevat...
Background: Low-molecular-weight heparin has greatly simpli-fied the management of deep venous throm...
...Background Low-molecular-weight heparin has a number of pharmacological and pharmacokinetic advan...
Background: Unfractionated heparin is often used as adjunctive therapy with fibrinolysis in patients...
Aims: The aim of the study was to compare outcomes in unfractionated heparin (UFH) and bivalirudin-t...
Background: Unfractionated heparin (UFH) is frequently administered before percutaneous coronary int...
Background: The aim of the current study was to perform two separate meta-analyses of available stud...
This systematic review with meta-analysis sought to determine the efficacy and safety of unfractiona...
AbstractThis systematic review with meta-analysis sought to determine the efficacy and safety of unf...
BACKGROUND: Whether low-molecular-weight heparin (LMWH) is superior to unfractionated heparin (UFH) ...
Background Despite its limitations, unfractionated heparin (UFH) is the recommended anticoagulant du...
SummaryBackgroundWhether low molecular weight heparin (LMWH) enoxaparin is equivalent to unfractiona...
Background Low-molecular-weight heparin has a number of pharmacological and pharmacokinetic advantag...
PURPOSE: To obtain reliable estimates of the relative efficacy and safety of low-molecular-weight he...
Background: Despite the overwhelming progress that has been accomplished in the prevention of mortal...
BackgroundLow-molecular-weight heparins have recently been introduced in the management of ST elevat...
Background: Low-molecular-weight heparin has greatly simpli-fied the management of deep venous throm...
...Background Low-molecular-weight heparin has a number of pharmacological and pharmacokinetic advan...
Background: Unfractionated heparin is often used as adjunctive therapy with fibrinolysis in patients...
Aims: The aim of the study was to compare outcomes in unfractionated heparin (UFH) and bivalirudin-t...
Background: Unfractionated heparin (UFH) is frequently administered before percutaneous coronary int...